We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Samy Suissa

Samy Suissa PhD, FRSC, FCAHS

Distinguished James McGill Professor of Epidemiology, Biostatistics and Medicine, McGill University; Director, Centre For Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, Montreal, Quebec, Canada

Samy Suissa is Director of the Centre for Clinical Epidemiology, Lady Davis Institute of the Jewish General Hospital, and a Distinguished James McGill Professor of Epidemiology and Biostatistics, and Medicine, at McGill University, Montreal, Canada. He heads the Canadian Network for Observational Drug Effect Studies (CNODES).

Professor Suissa has conducted several studies on the real world effects of medications used for different chronic diseases, including respiratory, cardiovascular, diabetes, rheumatoid arthritis, cancer and women’s health. He specializes in research methods and authored over 500 peer-reviewed papers. He has served on the editorial boards of various scientific journals, including Pharmacoepidemiology and Drug Safety, the European Respiratory Journal, Chest, Lancet Respiratory Medicine, Multidisciplinary Respiratory Medicine, and the Journal of COPD.

He is a fellow of the Royal Society of Canada and of the Canadian Academy of Health Science, has received the Distinguished Investigator award from the Canadian Institute of Health Research and the FC Donders Professorship Award from Universiteit Utrecht, Netherlands.


Dr. Suissa is on the Scientific Advisory Board of the EMPRISE study funded by Boehringer-Ingelheim.